This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xie, R.-L. Articles by Stein, G. S. Search for Related Content PubMed PubMed Citation Articles by Xie, R.-L. Articles by Stein, G. S.

Forced Expression of the Interferon Regulatory Factor 2 Oncoprotein Causes Polyploidy and Cell Death in FDC-P1 Myeloid Hematopoietic Progenitor Cells¹

Department of Cell Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01655

The IFN regulatory factor-2 (IRF-2) oncoprotein controls the cell cycle-dependent expression of histone H4 genes during S phase and may function as a component of an E2F-independent mechanism to regulate cell growth. To investigate the role of IRF-2 in control of cell proliferation, we have constructed a stable FDC-P1 cell line (F2) in which expression of IRF-2 is doxycycline (DOX)-inducible, and a control cell line (F0). Both the F2 and F0 cell lines were synchronized in the G₁ phase by isoleucine deprivation, and IRF-2 was induced by DOX on release of cells from the cell cycle block. Flow cytometric analyses indicated that forced expression of IRF-2 has limited effects on cell cycle progression before the first mitosis. However, continued cell growth in the presence of elevated IRF-2 levels results in polyploidy (>4n) or genomic disintegration (<2n) and cell death. Western blot analyses revealed that the levels of the cell cycle regulatory proteins cyclin B1 and the cyclin-dependent kinase (CDK)-inhibitory protein p27 are selectively increased. These changes occur concomitant with a significant elevation in the levels of the FAS-L protein, which is the ligand of the FAS (Apo1/CD95) receptor. We also found a subtle change in the ratio of the apoptosis-promoting Bax protein and the antiapoptotic Bcl-2 protein. Hence, IRF-2 induces a cell death response involving the Fas/FasL apoptotic pathway in FDC-P1 cells. Our data suggest that the IRF-2 oncoprotein regulates a critical cell cycle checkpoint that controls progression through G₂ and mitosis in FDC-P1 hematopoietic progenitor cells.

This article has been cited by other articles:

				R. Xie, R. Medina, Y. Zhang, S. Hussain, J. Colby, P. Ghule, S. Sundararajan, M. Keeler, L.-J. Liu, M. van der Deen, et al. The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles PNAS, July 28, 2009; 106(30): 12359 - 12364. [Abstract] [Full Text] [PDF]

				M. Koeppel, S. J. van Heeringen, L. Smeenk, A. C. Navis, E. M. Janssen-Megens, and M. Lohrum The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response Nucleic Acids Res., February 1, 2009; 37(2): 322 - 335. [Abstract] [Full Text] [PDF]

				P. Mitra, R.-L. Xie, R. Medina, H. Hovhannisyan, S. K. Zaidi, Y. Wei, J. W. Harper, J. L. Stein, A. J. van Wijnen, and G. S. Stein Identification of HiNF-P, a Key Activator of Cell Cycle-Controlled Histone H4 Genes at the Onset of S Phase Mol. Cell. Biol., November 15, 2003; 23(22): 8110 - 8123. [Abstract] [Full Text] [PDF]

				R.-L. Xie, S. Gupta, A. Miele, D. Shiffman, J. L. Stein, G. S. Stein, and A. J. van Wijnen The Tumor Suppressor Interferon Regulatory Factor 1 Interferes with SP1 Activation to Repress the Human CDK2 Promoter J. Biol. Chem., July 11, 2003; 278(29): 26589 - 26596. [Abstract] [Full Text] [PDF]